Aquaporin-1 antibody in neuromyelitis optica patients

European Neurology

Volumn 72, Issue 5-6, 2014, Pages 271-272

  Tüzün, Erdem ^a   Tzartos, John ^c   Ekizoʇlu, Esme ^a   Stergiou, Christos ^c   Zisimopoulou, Paraskevi ^c   Çoban, Arzu ^a   Shugaiv, Erkingül ^a   Türkoʇlu, Recai ^b   Kürtüncü, Murat ^a   Baykan, Betül ^a   Tzartos, Socrates ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Antibody; Aquaporin 1; Aquaporin 4; Autoimmunity; Neuromyelitis optica

Indexed keywords

AQUAPORIN 1; AQUAPORIN 1 ANTIBODY; AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; UNCLASSIFIED DRUG; AQP1 PROTEIN, HUMAN; AQP4 PROTEIN, HUMAN; AQUAPORIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; HEK293 CELL LINE; IMMUNOLOGY; RADIOIMMUNOPRECIPITATION;

ADULT; AQUAPORIN 1; AQUAPORIN 4; AUTOANTIBODIES; FEMALE; HEK293 CELLS; HUMANS; MALE; NEUROMYELITIS OPTICA; RADIOIMMUNOPRECIPITATION ASSAY;

EID: 84927743529     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000364904     Document Type: Article

References (10)

1. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
2. Siritho S, Nakashima I, Takahashi T, Fujihara K, Prayoonwiwat N: AQP4 antibody-positive Thai cases: clinical features and diagnostic problems. Neurology 2011; 77: 827-834.
3. Akman-Demir G, Tüzün E, Waters P, Içöz S, Kürtüncü M, Jarius S, Yap?c? Z, Mutlu M, Ye?ilot N, Vincent A, Eraksoy M: Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 2011; 258: 464-470.
4. Tzartos JS, Stergiou C, Kilidireas K, Zisimopoulou P, Thomaidis T, Tzartos SJ: Antiaquaporin-autoantibodies in patients with neuromyelitis optica spectrum disorders. PLoS One 2013; 8:e74773.
5. Benga O, Huber VJ: Brain water channel proteins in health and disease. Mol Aspects Med 2012; 33: 562-578.
6. Satoh J, Tabunoki H, Yamamura T, Arima K, Konno H: Human astrocytes express aquaporin-and aquaporin-4 in vitro and in vivo. Neuropathology 2007; 27: 245-256.
7. Misu T, Höftberger R, Fujihara K, Wimmer I, Takai Y, Nishiyama S, Nakashima I, Konno H, Bradl M, Garzuly F, Itoyama Y, Aoki M, Lassmann H: Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 2013; 125: 815-827.
8. Polman CH, Reingold SC, Banwell B, et al: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
9. Ekizoglu E, Içoz S, Tuzun E, Birisik O, Kocasoy-Orhan E, Akman-Demir G, Baykan B: Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension. Cephalalgia 2012; 32: 198-202.
10. Dhungana S, Waters P, Ismail A, Woodroofe N, Vincent A, Sharrack B: Absence of aquaporin-antibodies in patients with idiopathic intracranial hypertension. J Neurol 2010; 257: 1211-1212.